Hoelscher Paul W.
- SEC CIK
- 0001611468
No open-market purchases or sales filed in the past year.
Current role at each company
- SGMT Sagimet Biosciences Inc.Directoras of Jun 15, 2026
- OKUR OnKure Therapeutics, Inc.Directoras of Jun 8, 2023
- HZNP Horizon Therapeutics Public Ltd CoEVP, CFOas of Apr 22, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hoelscher Paul W. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HZNP Horizon Therapeutics Public Ltd Co
EVP, CFO6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2022 (view filing) | Apr 20 | 2 days | Hoelscher Paul W.EVP, CFO | SSale | −50.0K | $114.71 | −$5.74M | −97.9%1.05K after | 2 lots |
| Apr 8, 2022 (view filing) | Apr 6 | 2 days | Hoelscher Paul W.EVP, CFO | SSale | −215.3K | $110.01 | −$23.7M | −99.5%1.05K after | |
| Apr 8, 2022 (view filing) | Apr 6 | 2 days | Hoelscher Paul W.EVP, CFO | SSale | −91.7K | $110.01 | −$10.1M | −57.9%66.7K after | |
| Mar 25, 2022 (view filing) | Mar 23 | 2 days | Hoelscher Paul W.EVP, CFO | SSale | −26.1K | $110.00 | −$2.87M | −96.1%1.05K after | |
| Mar 25, 2022 (view filing) | Mar 23-25 | 2 days | Hoelscher Paul W.EVP, CFO | SSale | −13.8K | $110.01 | −$1.52M | −8.0%158.4K after | 3 lots |
| Dec 30, 2021 (view filing) | Dec 28 | 2 days | Hoelscher Paul W.EVP, CFO | SSale | −8.57K | $110.00 | −$943.3K | −89.1%1.05K after |